• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 89 of 100
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
Mylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Bill Ackman
Health
Valeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’
By Stephen GandelNovember 10, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
Astrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
Walgreens-Rite Aid deal could lead to elimination of 3,000 stores
Retail
Walgreens-Rite Aid deal could lead to elimination of 3,000 stores
By Phil WahbaNovember 5, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Turing Says it Will Lower Daraprim Price by the End of the Year
By Laura LorenzettiNovember 4, 2015
Fortune Global Forum 2015
Health
How the U.S. Subsidizes Europe’s Health Care Costs
By Beth KowittNovember 3, 2015
Hedge fund manager Bill Ackman
Finance
Bill Ackman on Valeant: ‘Life will go on’
By Stephen GandelOctober 30, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health
Valeant cuts ties to controversial pharmacy chain Philidor
By Geoffrey SmithOctober 30, 2015
Hedge fund manager Bill Ackman
Finance
Another one of Bill Ackman’s top stocks is down 50%
By Jen WiecznerOctober 29, 2015
A Starbucks cafe in Sanlitun. For the third quarter of 2015
Features
Pharma megadeal and Starbucks earnings — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithOctober 29, 2015
Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66 Billion
Health
When Viagra met Botox: Pfizer, Allergan eye mega-merger
By Geoffrey SmithOctober 29, 2015
Cholesterol lowering pill
Health
This drug will make your flu shot less effective
By TIMEOctober 29, 2015
1...
  • 87
  • 88
  • 89
  • 90
  • 91
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.